Carbon nanostructures for nanomedicine: Opportunities and challenges

Fullerenes Nanotubes and Carbon Nanostructures

Volumn 22, Issue 1-3, 2014, Pages 190-195

  Marchesan, Silvia ^a   Melchionna, Michele ^a   Prato, Maurizio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; CARBON NANOSTRUCTURES; CLINICAL APPLICATION; CLINICAL SETTINGS; FUNCTIONALIZATION OF CNTS; INNOVATIVE SOLUTIONS; NANOMEDICINES; PROTEIN CORONAS;

CARBON; NANODIAMONDS; NANOSTRUCTURES;

MEDICAL NANOTECHNOLOGY;

EID: 84892880992     PISSN: 1536383X     EISSN: 15364046     Source Type: Journal    
DOI: 10.1080/1536383X.2013.798726     Document Type: Article

References (33)

1. Feynman, R. P. (1960) There's plenty of room at the bottom. Eng. Sci. 23(5): 22-36.
2. European Science Foundation's forward look nanomedicine: An EMRC consensus opinion (2005) http://www.esf.org (accessed 18 November 2013).
3. Liu, Z., Tabakman, S., Welsher, K., and Dai, H. (2009) Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res., 2: 85-120.
4. Tran, P. A., Zhang, L., and Webster, T. J. (2009) Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv. Drug Deliv. Rev., 61: 1097-1114.
5. Morales-Narvaez, E. and Merkoci, A. (2012) Graphene oxide as an optical biosensing platform. Adv. Mat., 24: 3298-3308.
6. Mochalin, V. N., Shenderova, O., Ho, D., and Gogotsi, Y. (2012) The properties and applications of nanodiamonds. Nat. Nanotech., 7: 11-23.
7. Duncan, R. and Gaspar, R. (2011) Nanomedicine(s) under the microscope. Mol. Pharmaceutics, 8 (6): 2101-2141.
8. Mahmoudi, M., Lynch, I., Ejtehady, M. R., Monopoli, M. P., Baldelli-Bombelli, F., and Laurent, S. (2011) Protein-nanoparticle interactions: Opportunities and challenges. Chem. Rev., 111: 5610-5637.
9. Cai, X., Ramalingam, R., Wong, H. S., Cheng, J., Ajuh, P., Cheng, S. H., et al. (2012) Characterization of carbon nanotube protein corona by using quantitative proteomics. Nanomedicine: NBM. doi:10.1016/j.nano.2012.09.004.
10. Podila, R., Vedantam, P., Ke, P. C., Brown, J. M., and Rao, A. M. (2012) Evidence for chargetransfer-induced conformational changes in carbon nanostructure-protein corona. J. Phys. Chem. C, 116: 22098-22103.
11. Zhang, M., Mao, X., Wang, C., Zeng, W., Zhang, C., Li, Z., et al. (2013) The effect of graphene oxide on conformation change, aggregation and cytotoxicity of HIV-1 regulatory protein (Vpr). Biomaterials, 34: 1383-1390.
12. Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., et al. (2011) Binding of blood proteins to carbon nanotubes reduces cytotoxicity. PNAS U. S. A., 108(41): 16968-16973.
13. Hu, W., Peng, C., Lv, M., Li, X., Zhang, Y., Chen, N., Fan, C., and Huang, Q. (2011) Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano, 5(5): 3693-3700.
14. Maeda, H., Nakamura, H., and Fang, J. (2013) The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliver. Rev., 75(1): 71-79.
15. Moghini, S. M., Hunter, A. C., and Andresen, T. L. (2012) Factors controlling nanoparticle pharmacokinetics: An integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol., 52: 481-503.
16. Albanese, A., Tang, P. S., and Chan, W. C. W. (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng., 14: 1-16.
17. Daum, N, Tscheka, C., Neumeyer, A., and Schneider, M. (2012) Novel approaches for drug delivery systems in nanomedicine: Effects of particle design and shape. WIRE Nanomed. Nanobiotechnol., 4: 52-65.
18. Liu, X., Tao, H., Yang, K., Zhang, S., Lee, S.-T., and Liu, Z. (2011) Optimization of surface chemistry on single-walled carbon nanotubes for in vivo phototermal ablation of tumors. Biomaterials, 32: 144-151.
19. Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., and Dai, H. (2007) In vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice. Nat. Nanotech., 2: 47-52.
20. Al-Jamal, K., Nunes, A.,Methven, L., Ali-Boucetta, H., Li, S., Toma, F.M., Herrero,M. A., et al. (2012) Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile. Angew. Chem.-Int. Ed., 51: 6389-6393.
21. Al-Jamal,W. T. and Kostarelos, K. (2011) Liposomes. From a clinically established drug delivery system to a nanoparticle platform. Acc. Chem. Res., 44: 1094-1104.
22. Khandare, J., Calderón, M., Dagia, N. M., and Haag, R. (2012) Multifunctional dendritic polymers in nanomedicine: Opportunities and challenges. Chem. Soc. Rev., 41: 2824-2848.
23. Duncan, R. (2011) Polymer therapeutics as nanomedicines: New perspectives. Curr. Opin. Biotechnol., 22: 492-501.
24. Marchesan, S. and Prato, M. (2013) Nanomaterials for (Nano)medicine. ACS Med. Chem. Lett., 4(2): 147-149.
25. Lee, D.E., Koo, H., Sun, I.-C., Ryu, J. H., Kim, K., and Kwon, I. C. (2012) Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev., 41: 2656-2672.
26. Robinson, J. T.,Welsher, K., Tabakman, S. M., Sherlock, S. P.,Wang, H., Luong, R., and Dai, H. (2010) High performance in vivo Near-IR ( 1 μm) imaging and photothermal cancer therapy with carbon nanotubes. Nano. Res., 3(11): 779-793.
27. Fabbro, C., Ali-Boucetta, H., Da Ros, T., Kostarelos, K., Bianco, A., and Prato, M. (2012) Targeting carbon nanotubes against cancer. Chem. Commun., 48: 3911-3926.
28. Delogu, L. G., Vidili, G., Venturelli, E., Ménard-Moyon, C., Zoroddu, M. A., Pilo, G., Nicolussi, P., et al. (2012) Functionalized multi-walled carbon nanotubes as ultrasound contrast agents. Proc. Natl. Acad. Sci. USA, 109: 16612-16617.
29. Fabbro, A., Bosi, S., Ballerini, L., and Prato, M. (2012) Carbon nanotubes: Artificial nanomaterials to engineer single neurons and neuronal networks. ACS Chemical Neurosci., 3: 611-618.
30. Martinelli, V., Cellot, G., Toma, F.M., Long, C. S., Caldwell, J. H., Zentilin, L., Giacca, M., et al. (2012) Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myocytes. Nano. Lett., 12: 1831-1838.
31. Kostarelos, K., Bianco, A., and Prato, M. (2009) Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotech., 4: 627-633.
32. Bianco, A., Kostarelos, K., and Prato, M. (2011) Making carbon nanotubes biocompatible and biodegradable. Chem. Comm., 47: 10182-10188.
33. Ali-Boucetta, H., Nunes, A., Sainz, R., Herrero,M. A., Tian, B., Prato, M., et al. (2013) Asbestoslike pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew. Chem.-Int. Ed., 52: 2274-2278.